Kirin (KNBWY)
(Delayed Data from OTC)
$14.16 USD
+0.69 (5.14%)
Updated Aug 8, 2025 03:58 PM ET
3-Hold of 5 3
A Value C Growth D Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
KNBWY 14.16 +0.69(5.14%)
Will KNBWY be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for KNBWY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for KNBWY
KNBWY vs. BUD: Which Stock Is the Better Value Option?
Are Investors Undervaluing Kirin (KNBWY) Right Now?
KNBWY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Bear of the Day: Constellation Brands (STZ)
KNBWY or BUD: Which Is the Better Value Stock Right Now?
Is Kirin (KNBWY) Stock Undervalued Right Now?
Other News for KNBWY
Kirin Holdings: Q1 Performance Had Mixed Takeaways
Kirin Holdings: Promising Health Science Growth Amidst Pharmaceutical Challenges, Hold Rating Maintained
Kirin Holdings: Hold Rating Amid Disappointing Q1 Results and Margin Challenges